These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 8111711)

  • 1. Primary prognostic factors in invasive breast cancer with special reference to ductal carcinoma and histologic malignancy grade.
    Garne JP; Aspegren K; Linell F; Rank F; Ranstam J
    Cancer; 1994 Mar; 73(5):1438-48. PubMed ID: 8111711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Linell classification of breast cancer morphology compared to histologic grading, S-phase fraction and DNA-ploidy.
    Söderström J; Arnerlöv C; Emdin SO; Lundgren B; Roos G; Bjersing L; Norberg C; Angquist KA
    Pathol Res Pract; 1997; 193(7):485-90. PubMed ID: 9342754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A retrospective review with long term follow up of 11,400 cases of pure mucinous breast carcinoma.
    Di Saverio S; Gutierrez J; Avisar E
    Breast Cancer Res Treat; 2008 Oct; 111(3):541-7. PubMed ID: 18026874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A proposal for a new histological classification scheme for predicting short-term tumor recurrence and death in patients with invasive ductal carcinoma of the breast.
    Hasebe T; Imoto S; Sasaki S; Mukai K
    Jpn J Cancer Res; 1998 Dec; 89(12):1358-73. PubMed ID: 10081498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Grading system for lymph vessel tumor emboli: significant outcome predictor for invasive ductal carcinoma of the breast.
    Hasebe T; Okada N; Iwasaki M; Akashi-Tanaka S; Hojo T; Shibata T; Sasajima Y; Tsuda H; Kinoshita T
    Hum Pathol; 2010 May; 41(5):706-15. PubMed ID: 20060154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Grade of ductal carcinoma in situ accompanying infiltrating ductal carcinoma as an independent prognostic factor.
    Kim JY; Han W; Moon HG; Park IA; Ahn SK; Kim J; Lee JW; Kim T; Kim MK; Noh DY
    Clin Breast Cancer; 2013 Oct; 13(5):385-91. PubMed ID: 23870857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary tumour-vessel tumour-nodal tumour classification for patients with invasive ductal carcinoma of the breast.
    Hasebe T; Sasaki S; Imoto S; Wada N; Ishii G; Ochiai A
    Br J Cancer; 2005 Mar; 92(5):847-56. PubMed ID: 15756255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of clinical outcomes between luminal invasive ductal carcinoma and luminal invasive lobular carcinoma.
    Adachi Y; Ishiguro J; Kotani H; Hisada T; Ichikawa M; Gondo N; Yoshimura A; Kondo N; Hattori M; Sawaki M; Fujita T; Kikumori T; Yatabe Y; Kodera Y; Iwata H
    BMC Cancer; 2016 Mar; 16():248. PubMed ID: 27015895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is survival from infiltrating lobular carcinoma of the breast different from that of infiltrating ductal carcinoma?
    Jayasinghe UW; Bilous AM; Boyages J
    Breast J; 2007; 13(5):479-85. PubMed ID: 17760669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modified primary tumour/vessel tumour/nodal tumour classification for patients with invasive ductal carcinoma of the breast.
    Hasebe T; Iwasaki M; Akashi-Tanaka S; Hojo T; Shibata T; Sasajima Y; Kinoshita T; Tsuda H
    Br J Cancer; 2011 Aug; 105(5):698-708. PubMed ID: 21811256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Proliferation index and its prognostic value in invasive ductal breast carcinoma].
    Falco M
    Ann Acad Med Stetin; 2009; 55(1):22-30. PubMed ID: 20349588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative analysis of clinicopathologic characteristics and molecular subtypes of invasive papillary carcinoma of the breast and invasive ductal carcinoma: results from SEER database.
    Chen S; Wang J; Yang L; Ji M; Chen S
    J BUON; 2021; 26(5):1991-2002. PubMed ID: 34761609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lobular breast cancer: same survival and local control compared with ductal cancer, but should both be treated the same way? analysis of an institutional database over a 10-year period.
    Fortunato L; Mascaro A; Poccia I; Andrich R; Amini M; Costarelli L; Cortese G; Farina M; Vitelli C
    Ann Surg Oncol; 2012 Apr; 19(4):1107-14. PubMed ID: 21913022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Invasive micropapillary carcinoma of the breast has a better long-term survival than invasive ductal carcinoma of the breast in spite of its aggressive clinical presentations: a comparison based on large population database and case-control analysis.
    Chen H; Wu K; Wang M; Wang F; Zhang M; Zhang P
    Cancer Med; 2017 Dec; 6(12):2775-2786. PubMed ID: 29072365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic options and results for the management of minimally invasive carcinoma of the breast: influence of axillary dissection for treatment of T1a and T1b lesions.
    White RE; Vezeridis MP; Konstadoulakis M; Cole BF; Wanebo HJ; Bland KI
    J Am Coll Surg; 1996 Dec; 183(6):575-82. PubMed ID: 8957459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histologic grade remains a prognostic factor for breast cancer regardless of the number of positive lymph nodes and tumor size: a study of 161 708 cases of breast cancer from the SEER Program.
    Schwartz AM; Henson DE; Chen D; Rajamarthandan S
    Arch Pathol Lab Med; 2014 Aug; 138(8):1048-52. PubMed ID: 25076293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in Prognostic Factors and Failure Patterns Between Invasive Micropapillary Carcinoma and Carcinoma With Micropapillary Component Versus Invasive Ductal Carcinoma of the Breast: Retrospective Multicenter Case-Control Study (KROG 13-06).
    Yu JI; Choi DH; Huh SJ; Cho EY; Kim K; Chie EK; Ha SW; Park IA; Ahn SJ; Lee JS; Shin KH; Kwon Y; Kim YB; Suh CO; Koo JS; Kim JH; Jeong BG; Kim IA; Lee JH; Park W
    Clin Breast Cancer; 2015 Oct; 15(5):353-61.e1-2. PubMed ID: 25776197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibrotic focus in invasive ductal carcinoma of the breast: a histopathological prognostic parameter for tumor recurrence and tumor death within three years after the initial operation.
    Hasebe T; Tsuda H; Tsubono Y; Imoto S; Mukai K
    Jpn J Cancer Res; 1997 Jun; 88(6):590-9. PubMed ID: 9263537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Invasive lobular carcinoma of the breast has better short- and long-term survival than invasive ductal carcinoma.
    Toikkanen S; Pylkkänen L; Joensuu H
    Br J Cancer; 1997; 76(9):1234-40. PubMed ID: 9365176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative Long-term Study of a Large Series of Patients with Invasive Ductal Carcinoma and Invasive Lobular Carcinoma. Loco-Regional Recurrence, Metastasis, and Survival.
    García-Fernández A; Lain JM; Chabrera C; García Font M; Fraile M; Barco I; Torras M; Reñe A; González S; González C; Piqueras M; Veloso E; Cirera L; Pessarrodona A; Giménez N
    Breast J; 2015; 21(5):533-7. PubMed ID: 26190560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.